title: Maternal and fetal leptin, adiponectin levels and associations with fetal insulin sensitivity.
abstract: OBJECTIVE
  It remains uncertain whether leptin and adiponectin levels are correlated in maternal vs. fetal circulations. Little is known about whether leptin and adiponectin affect insulin sensitivity during fetal life.
  
  
  METHODS
  In a prospective singleton pregnancy cohort (n = 248), we investigated leptin and adiponectin concentrations in maternal (at 24-28 and 32-35 weeks of gestation) and fetal circulations, and their associations with fetal insulin sensitivity (glucose/insulin ratio, proinsulin level).
  
  
  RESULTS
  Comparing concentrations in cord vs. maternal blood, leptin levels were 50% lower, but adiponectin levels more than doubled. Adjusting for gestational age at blood sampling, consistent and similar positive correlations (correlation coefficients: 0.31-0.34, all P < 0.0001) were observed in leptin or adiponectin levels in maternal (at 24-28 or 32-25 weeks of gestation) vs. fetal circulations. For each SD increase in maternal plasma concentration at 24-28 weeks, cord plasma concentration increased by 12.7 (95% confidence interval 6.8-18.5) ng/ml for leptin, and 2.9 (1.8-4.0) µg/ml for adiponectin, respectively (adjusted P < 0.0001). Fetal insulin sensitivity was negatively associated with cord blood leptin (each SD increase was associated with a 5.4 (2.1-8.7) mg/dl/µU/ml reduction in cord plasma glucose/insulin ratio, and a 5.6 (3.9, 7.4) pmol/l increase in proinsulin level, all adjusted P < 0.01) but not adiponectin (P > 0.4) levels). Similar associations were observed in nondiabetic full-term pregnancies (n = 211).
  
  
  CONCLUSIONS
  The results consistently suggest a maternal impact on fetal leptin and adiponectin levels, which may be an early life pathway in maternal-fetal transmission of the propensity to obesity and insulin resistance.
authors.affiliation: Department of Obstetrics and Gynecology, CHU Sainte Justine, University of Montreal, Montreal, Quebec, Canada. zc_luo@yahoo.com
authors.forename: Zhong-Cheng
authors.initials: ZC
authors.lastname: Luo
authors.forename: Anne-Monique
authors.initials: AM
authors.lastname: Nuyt
authors.forename: Edgard
authors.initials: E
authors.lastname: Delvin
authors.forename: William D
authors.initials: WD
authors.lastname: Fraser
authors.forename: Pierre
authors.initials: P
authors.lastname: Julien
authors.forename: Francois
authors.initials: F
authors.lastname: Audibert
authors.forename: Isabelle
authors.initials: I
authors.lastname: Girard
authors.forename: Bryna
authors.initials: B
authors.lastname: Shatenstein
authors.forename: Cheri
authors.initials: C
authors.lastname: Deal
authors.forename: Emilie
authors.initials: E
authors.lastname: Grenier
authors.forename: Carole
authors.initials: C
authors.lastname: Garofalo
authors.forename: Emile
authors.initials: E
authors.lastname: Levy
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D005312:Fetal Blood / Q000378:metabolism*; D005333:Fetus / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood*; D009765:Obesity / Q000097:blood / Q000209:etiology*; D011247:Pregnancy; D011446:Prospective Studies
chemical_list: D052242:Adiponectin; D001786:Blood Glucose; D007328:Insulin; D020738:Leptin